Essex Bio-Technology Limited (HKG:1061)

Essex Bio-Technology Revenue

Essex Bio-Technology had revenue of 784.69M HKD in the half year ending June 30, 2026, a decrease of -5.29%. This brings the company's total for the last twelve months to 1.72B, up 0.24% year-over-year. In the year 2025, Essex Bio-Technology had annual revenue of 1.81B with 8.62% growth. That makes Essex Bio-Technology the 16,809th largest company in the world by revenue and 978th in Hong Kong.

• Revenue (ttm): 1.72B
• Revenue Growth: +0.24%
• P/S Ratio: 0.69
• Revenue / Employee: 1.39M
• Employees: 1,240
• Market Cap: 1.18B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Surgical 895.90M 49.4%
• Ophthalmology 835.03M 46.0%
• Healthcare and Partner Services 82.87M 4.6%

By Geography

Chart

• People's Republic of China (The PRC) 1.80B 99.4%
• Overseas 10.70M 0.6%

Fiscal year ended Dec 31, 2025 See the full Essex Bio-Technology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.81B	143.99M	8.62%
Dec 31, 2024	1.67B	-67.16M	-3.87%
Dec 31, 2023	1.74B	419.26M	31.82%
Dec 31, 2022	1.32B	-319.95M	-19.54%
Dec 31, 2021	1.64B	659.55M	67.43%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error